GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses like diabetes.

A new male birth control pill has passed early safety trials, showing promise with minimal side effects. Larger human trials ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Alnylam Pharmaceuticals, ...

As Epstein controversy swirls, President Trump signs an executive order aiming to give cities and states more authority to ...

The agency told Bayer it needs additional time to review the non-hormonal drug, called elinzanetant. Regulators in Canada and ...

Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...

A generic version of ibrutinib was granted tentative approval by the FDA for use in CLL and SLL with 17p deletion and ...

Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the ...

The FDA recently unveiled a new national priority voucher program that would seek to trade faster drug approvals for lower ...

Institutional investors including Armistice Capital, RTW Investments, and Wellington Management have increased their exposure ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3b AVA-PED-301 trial.

Doptelet and new oral sprinkle granules is approved for children one year and older with chronic immune thrombocytopenia, ...